April 23, 2014 7:35 PM ET


Company Overview of AbFrontier Co., Ltd.

Company Overview

AbFrontier Co., Ltd., a biotech company, produces polyclonal and monoclonal antibodies and proteins. It offers ROS signaling, neuroscience, serum protein, cell signaling, and specialized antibodies categories. The company also provides proteome analysis, DNA cloning, protein purification, antibody production, and virus construction services. In addition, it offers antibody manufacturing services. AbFrontier Co., Ltd. is based in Seoul, South Korea. As of April 29, 2008, AbFrontier Co., Ltd. operates as a subsidiary of Young in Frontier Co. Ltd.

11F., Byucksan Digital Valley 5th

Gasan-dong 60-73


Seoul,  153-801

South Korea


82 2 2140 3383


82 2 2140 3320

Key Executives for AbFrontier Co., Ltd.

AbFrontier Co., Ltd. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
KT&G Life Sciences Asia
WelGENE Inc. Asia
Histostem Co., Ltd. Asia
BioLeaders Corporation Asia
Know & Keep Your Genes Co., Ltd. Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AbFrontier Co., Ltd., please visit www.abfrontier.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.